A Study Evaluating the Association of Inflammation With Hemodialysis Access Type
Completed
Conditions studied: End Stage Renal Disease, Inflammation
In brief
To determine if the type of hemodialysis vascular access correlates with markers of inflammation, namely C-reactive protein and interleukin-6, and with both access and patient survival in the end stage renal disease population.
Key facts
- Study ID
- NCT01011985
- Run by
- Montefiore Medical Center
- People needed
- 64
- Starts
- 2006-08-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2018-07-09
Who can join
Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- CKD patients referred for their initial vascular access
- Able to consent for surgery/study
You may not qualify if…
- Active inflammatory states
- Active infection
- Autoimmune diseases
- Acute renal allograft rejection
- HIV positive status
Where it is running
- Montefiore Medical Center and Jack D Weiler Hospital — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.